Patent Application

The transition from invention to intellectual property protection represents one of the most critical junctures in the development of medical technology. The patent application phase determines whether your breakthrough innovation will receive the legal foundation necessary for commercial success. Failure to do this can mean costly oversights and derail years of research and development investment.

Patents fuel growth for MedTech companies. In today's innovative economy, a MedTech company's success depends on the strength and value of its patent portfolio. A strategic patent portfolio is crucial for a MedTech company's growth and survival and can help secure funding, which is vital for startups.

_{David Dykeman, Co-Chair of Global Life Sciences and Medical Technology Group}

This strategic investment in comprehensive patent protection ensures that your groundbreaking idea will reach the patients who need it most. This stage will require meticulous attention to detail, strategic foresight, and a deep understanding of both technical innovation and the legal frameworks that govern intellectual property in healthcare.

Prior art blind spots

Any successful patent application will need a thorough analysis of prior art. Medical technology operates within an expansive landscape of existing knowledge, where seemingly novel innovations may have been previously disclosed in academic papers, earlier patents, or even abandoned research projects. Prior art blind spots are the hidden threat to innovation and represent one of the most dangerous pitfalls in patent application strategy.

Comprehensive prior art searches need to extend beyond obvious sources to include international patent databases, scientific journals, conference proceedings, and even regulatory submissions that may contain technical disclosures. Medical device innovations often build upon established principles in unexpected ways, making exhaustive searches essential for identifying potential conflicts.

This complexity increases when considering that prior art can exist in multiple forms across different jurisdictions. A research paper published in a European journal, a patent filed in Japan, or even a presentation at a medical conference can constitute prior art that invalidates novelty claims. Your search strategy will need to account for these diverse sources, considering variations in terminology, technical approaches, and regional development patterns.

Poor claim scope

Patent claims represent the legal boundaries that define invention scope and determine protection strength. Drafting effective claims requires a precise balance between breadth and specificity. Too narrow, and competitors can easily design around the patent. Too broad, and examiners will reject applications for being obvious.

Medical device patents face unique challenges in claim drafting due to the interdisciplinary nature of healthcare innovation. A single device may incorporate mechanical engineering, materials science, software algorithms, and biological interfaces. Each component requires careful consideration to ensure comprehensive protection without overreaching into established art. The most effective patent applications will use claim hierarchies that provide multiple levels of protection, including any potential future improvements. This layered approach will create comprehensive protection that makes it difficult for your competitors to circumvent.

Premature disclosure

Public disclosure before patent filing represents one of the most catastrophic errors in intellectual property strategy. Once technical details are publicly shared through publications, presentations, or product demonstrations, your patent rights could be permanently compromised in many jurisdictions worldwide.

Healthcare creates numerous disclosure temptations. Academic researchers seek publication opportunities, clinical investigators present at conferences, and business development teams engage in partnership discussions. Each interaction carries potential disclosure risks that must be carefully managed through non-disclosure agreements and strategic communication protocols.

Social media and digital communications only amplify these disclosure risks. Technical discussions in online forums, detailed product descriptions on websites, or even casual conversations recorded on video can constitute public disclosures that undermine patent applications. You’ll need to create a comprehensive disclosure management system that protects any sensitive information during your business activities.

A one-year grace period will provide limited protection, but these safeguards are inconsistent globally and create unnecessary risks. An effective patent strategy will help you to prioritise filing before any public disclosure to protect your invaluable innovation.

Inventor and ownership gaps

Medical device development typically involves teams where individual contributions may be difficult to isolate and evaluate. Inventor identification requires careful analysis of creative contributions to patentable concepts, distinguishing between those who conceived the inventive idea and those who merely turn concept into practice.

Meanwhile, ownership disputes can also emerge when employment agreements are unclear, consultants contribute to development without proper IP assignments, or collaborative relationships lack defined intellectual property terms. These gaps can result in co-ownership situations that complicate the commercialisation of your idea or create disputes that undermine the patent value.

This can be similar for University partnerships, which present particular challenges for ownership. Academic institutions often retain rights to faculty inventions, while industry partners seek exclusive control over jointly developed technologies. Clear agreements need to be established before collaborative work begins to prevent conflicts of interest.

Global strategy considerations

Think beyond borders. Medical technologies operate in global markets where patent protection must align with commercial objectives across multiple jurisdictions. Failing to develop a comprehensive international filing strategy will limit your market access and create opportunities for competitors to exploit any unprotected territories.

Patent Cooperation Treaty (PCT) applications provide efficient mechanisms for establishing international priority while deferring individual country filing decisions. This approach will allow your patent strategies to evolve based on market assessments, regulatory developments, and competitive landscapes that emerge during prosecution periods.

Regional patent systems, including the European Patent Office and other multinational frameworks, offer cost-effective protection for groups of countries with similar market characteristics. Keep careful consideration of validation requirements, enforcement mechanisms, and any local patent law variations.

The imperative of specialised expertise

Medical technology patent applications require specialised knowledge that spans technical innovation, regulatory requirements, and commercial strategy. Patent attorneys with MedTech expertise understand the unique challenges facing healthcare innovations and can navigate complex application processes, while avoiding those common pitfalls.

Early engagement with specialised patent counsel ensures that invention documentation, prior art analysis, and application strategy align with both immediate protection needs and long-term commercial objectives. This proactive approach prevents costly corrections and maximises patent value throughout development and commercialisation phases.

Unfortunately, many European medtech companies fail to approach patent portfolio development strategically, often spending more money than necessary without securing adequate protection or losing investors in the due diligence process.

_{Foley & Lardner}

Waypoint checklist

Here’s a patent application checklist to guide you along the way:

• Prior Art Blind Spots with missing existing patents and publications.
• Poor Claim Scope by drafting claims that are either too narrow or too broad.
• Premature disclosure when publicly sharing tech before filing will kill patent rights.
• Ownership gaps with unlisted contributors or unsigned assignments risks future disputes.
• No global strategy means failure to file internationally will limit market protection.
• Involve a MedTech-specialised patent attorney early to spot the pitfalls.

Need help with your patent application?

This vital process requires expert guidance and rigorous methodology. We can help you check and protect the IP of your groundbreaking device.